CVE-2025-61624: Fortinet Multiple Products Path Traversal Vulnerability

What is known

An Improper Limitation of a Pathname to a Restricted Directory ('Path Traversal') [CWE-22] vulnerability in Fortinet FortiOS 7.6.0 through 7.6.4, FortiOS 7.4.0 through 7.4.9, FortiOS 7.2 all versions, FortiOS 7.0 all versions, FortiOS 6.4 all versions, FortiPAM 1.7.0, FortiPAM 1.6 all versions, FortiPAM 1.5 all versions, FortiPAM 1.4 all versions, FortiPAM 1.3 all versions, FortiPAM 1.2 all versions, FortiPAM 1.1 all versions, FortiPAM 1.0 all versions, FortiProxy 7.6.0 through 7.6.4, FortiProxy 7.4.0 through 7.4.11, FortiProxy 7.2 all versions, FortiProxy 7.0 all versions, FortiSwitchManager 7.2.0 through 7.2.7, FortiSwitchManager 7.0.0 through 7.0.6 may allow an authenticated attacker with admin profile and at least read-write permissions to write or delete arbitrary files via specific CLI commands.

Business impact

Successful exploitation of CVE-2025-61624, a medium vulnerability (CVSS 6.0) affecting Multiple Products, may affect the confidentiality, integrity or availability of the vulnerable environment. The exact impact depends on the installed version, exposed interfaces and deployment configuration. CISA lists this vulnerability in the Known Exploited Vulnerabilities catalog, so exposed systems should be treated as a priority.

Recommended administrator action

Confirm whether Multiple Products is present and compare installed versions with the vendor advisory and NVD record. Apply the vendor patch or documented mitigation; until remediation is complete, reduce exposure of affected interfaces, review relevant logs and monitor for indicators of exploitation. Where applicable, include the CISA KEV remediation due date of 2026-10-19 in the change plan. DataHouse can support version verification, managed patching, network exposure reduction, log review and backup validation for dedicated, cloud and colocated environments.

Sources

• NVD
• CISA KEV
• Reference
• Reference
• Reference
• Reference